Usa covid-19 vaccine prevention Usa

Moderna to get additional $472m from BARDA for Covid-19 vaccine

Reading now: 393
www.pharmaceutical-technology.com

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Moderna and the US Biomedical Advanced Research and Development Authority (BARDA) have updated their contract for an additional funding commitment of up to $472m.

The funding will support the late-stage clinical development of the company’s Covid-19 vaccine candidate, mRNA-1273, including the expanded Phase III clinical trial.

Previously, BARDA agreed to provide up to $483m for the scale-up of the vaccine and clinical development, which was supposed to involve a smaller number of participants in the Phase III study.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA